<code id='1229DC5058'></code><style id='1229DC5058'></style>
    • <acronym id='1229DC5058'></acronym>
      <center id='1229DC5058'><center id='1229DC5058'><tfoot id='1229DC5058'></tfoot></center><abbr id='1229DC5058'><dir id='1229DC5058'><tfoot id='1229DC5058'></tfoot><noframes id='1229DC5058'>

    • <optgroup id='1229DC5058'><strike id='1229DC5058'><sup id='1229DC5058'></sup></strike><code id='1229DC5058'></code></optgroup>
        1. <b id='1229DC5058'><label id='1229DC5058'><select id='1229DC5058'><dt id='1229DC5058'><span id='1229DC5058'></span></dt></select></label></b><u id='1229DC5058'></u>
          <i id='1229DC5058'><strike id='1229DC5058'><tt id='1229DC5058'><pre id='1229DC5058'></pre></tt></strike></i>

          entertainment

          entertainment

          author:explore    Page View:88
          Tome cofounders Jonathan Gootenberg, left, and Omar Abudayyeh, a scientific team that's trying to reinvent gene editing for a new era of biotech innovation.
          Suzanne Kreiter/Globe staff

          WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

          Together, Omar Abudayyeh, 33, and Jonathan Gootenberg, 32, have probed the mysteries of genomic editing and COVID detection. They co-published 10 scientific papers, helped launch two medical-diagnostic companies, and cofounded a Watertown startup, Tome Biosciences, that reengineers genes and cells to cure diseases. They also run the Abudayyeh-Gootenberg Lab at Harvard.

          advertisement

          Gootenberg and Abudayyeh are an unusual pair, two scientists — a Jewish American and a Palestinian American — who prefer working together in a field that often draws solitary researchers and rewards individual achievement.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          Supreme Court strikes down use of affirmative action
          Supreme Court strikes down use of affirmative action

          ActivistsdemonstratedastheSupremeCourtheardoralargumentsonapairofaffirmativeactioncasesinOctober2022

          read more
          Stanford president's case begs question: Who takes blame?
          Stanford president's case begs question: Who takes blame?

          PalmDriveattheentrancetoStanfordUniversity.BrianFrankforSTATTheresignationofMarcTessier-Lavigneaspre

          read more
          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more

          7 more heat

          1:25Abillboarddisplaysatemperatureof118degreesFahrenheitduringarecordheatwaveinPhoenix,ArizonaonJuly